Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 2
Results: 13
1
2
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
3
Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
Identification of the critical genes and miRNAs in hepatocellular carcinoma by integrated bioinformatics analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
5
Exosome application in tumorigenesis: diagnosis and treatment of melanoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
6
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
8
CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction.
- Published in:
- 2022
- By:
- Publication type:
- journal article
9
LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
10
Novel molecules as the emerging trends in cancer treatment: an update.
- Published in:
- 2022
- By:
- Publication type:
- journal article
11
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model.
- Published in:
- Medical Oncology, 2022, v. 39, n. 2, p. 1, doi. 10.1007/s12032-021-01612-9
- By:
- Publication type:
- Article
12
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway.
- Published in:
- 2022
- By:
- Publication type:
- journal article
13
IL-33 induces ADAMTS5 expression and cell migration in glioblastoma multiforme.
- Published in:
- 2022
- By:
- Publication type:
- journal article